Related Experiment Video
Updated: Apr 1, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for
S Faithfull1, A Lemanska1, T Chen2
1School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Abstract:
Patient-reported outcome measures (PROMs) are a useful way of recording patient perceptions of the impact of their cancer and the consequences of treatment. Understanding the impact of radiotherapy longer term requires tools that are sensitive to change but also meaningful for patients. PROMs are useful in defining symptom severity but also the burden of illness for cancer patients. Patient-reported outcomes are increasingly being seen as a way to improve practice by enhancing communication, improving symptom management as well as identifying patient care needs. This paper provides an overview of the use of PROMs in radiotherapy and considerations for tool choice, analysis and the logistics of routine data collection. Consistent assessment is essential to detect patient problems as a result of radiotherapy, but also to address emerging symptoms promptly.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Kaplan-Meier Approach
Treatment Resistent Cancers
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Biological Effects of Radiation

